p27 in FLT3-driven acute myeloid leukemia: many roads lead to ruin.

about

p27 in FLT3-driven acute myeloid leukemia: many roads lead to ruin.

Item

http://www.wikidata.org/entity/Q42341693

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

p27 in FLT3-driven acute myeloid leukemia: many roads lead to ruin.

@en

p27 in FLT3-driven acute myeloid leukemia: many roads lead to ruin.

@nl

type

Item

label

p27 in FLT3-driven acute myeloid leukemia: many roads lead to ruin.

@en

p27 in FLT3-driven acute myeloid leukemia: many roads lead to ruin.

@nl

prefLabel

p27 in FLT3-driven acute myeloid leukemia: many roads lead to ruin.

@en

p27 in FLT3-driven acute myeloid leukemia: many roads lead to ruin.

@nl

P1476

p27 in FLT3-driven acute myeloid leukemia: many roads lead to ruin

@en

P2093

Florian Bellutti

http://www.w3.org/2001/XMLSchema#string

Veronika Sexl

http://www.w3.org/2001/XMLSchema#string

P2860

Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.

The murine gene p27Kip1 is haplo-insufficient for tumour suppression.

Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.

Induced protein degradation: an emerging drug discovery paradigm.

BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein.

The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.

Pim-1 kinase phosphorylates and stabilizes 130 kDa FLT3 and promotes aberrant STAT5 signaling in acute myeloid leukemia with FLT3 internal tandem duplication

New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?

Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia.

P304

1299-1301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3324/HAEMATOL.2017.171819

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Iris Z Uras

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28760806

http://www.w3.org/2001/XMLSchema#string

P932

5541863

http://www.w3.org/2001/XMLSchema#string